SEC Filing Summary: Bellevue Life Sciences Acquisition Corp. (BLAC)
Business Context and Reporting Period
This Form 8-K was filed on October 22, 2024, reporting events occurring on October 16, 2024. The registrant is Bellevue Life Sciences Acquisition Corp., a Delaware corporation and emerging growth company. The filing details the entry into a material definitive agreement involving the creation of a direct financial obligation.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The primary financial metric disclosed is the issuance of a new debt instrument:
- Principal Amount: $800,000
- Lender: Duksung Co., LTD.
- Interest Rate: 5% per annum (simple); 7% per annum if prepaid following the PIPE Outside Date.
- Maturity Date: October 15, 2025.
- Conversion Price: $8.10 per share upon a Qualified PIPE Financing.
Material Changes
The material change reported is the creation of a new unsecured promissory note obligation. This represents a new liability on the company's balance sheet effective October 16, 2024. No prior comparable period data is provided in this specific filing to assess changes in operating performance.
Outlook, Risks, and Contingencies
The repayment and conversion of the note are contingent upon the closing of a "Qualified PIPE Financing."
- Conversion Trigger: If a Qualified PIPE Financing closes, the note automatically converts into common stock at $8.10 per share, satisfying the debt obligation.
- Prepayment Option: If a Qualified PIPE Financing does not occur by March 31, 2025 (the "PIPE Outside Date"), the company may prepay the note in whole or in part. Prepayment requires payment of principal plus accrued interest at 7%.
- Risk: The company faces a liquidity obligation if the PIPE financing fails to materialize by the specified deadline, requiring cash repayment at a higher interest rate.
Investor Verification Checklist
- Verify the definition of "Qualified PIPE Financing" in the full text of the Promissory Note (Exhibit 10.1) to understand the specific conditions required for debt conversion.
- Confirm the company's current cash position and ability to repay the $800,000 principal plus 7% interest if the PIPE financing does not close by March 31, 2025.
- Review the dilution impact on existing shareholders if the note converts at the $8.10 price point.
- Check for any subsequent filings regarding the status of the PIPE financing negotiations.